[HTML][HTML] Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence
X Han, X Xu, Z Wu, Z Wu, X Qi - Acta Pharmaceutica Sinica B, 2021 - Elsevier
The functionality of DNA biomacromolecules has been widely excavated, as therapeutic
drugs, carriers, and functionalized modification derivatives. In this study, we developed a …
drugs, carriers, and functionalized modification derivatives. In this study, we developed a …
Self-assembled DNA nanostructure as a carrier for targeted siRNA delivery in glioma cells
Y Zhou, Q Yang, F Wang, Z Zhou, J Xu… - International Journal …, 2021 - Taylor & Francis
Introduction RNA interference is a promising therapy in glioma treatment. However, the
application of RNA interference has been limited in glioma therapy by RNA instability and …
application of RNA interference has been limited in glioma therapy by RNA instability and …
Self-assembled double-bundle DNA tetrahedron for efficient antisense delivery
DNA nanostructures are promising biomaterials capable of arranging multiple functional
components with nanometer precision. Here, a double-bundle DNA tetrahedron is rationally …
components with nanometer precision. Here, a double-bundle DNA tetrahedron is rationally …
Optimized DNA “nanosuitcases” for encapsulation and conditional release of siRNA
KE Bujold, JCC Hsu, HF Sleiman - Journal of the American …, 2016 - ACS Publications
We set out to design, synthesize, and optimize a DNA-minimal cage capable of
encapsulating oligonucleotide drugs to facilitate their delivery. Through rational design and …
encapsulating oligonucleotide drugs to facilitate their delivery. Through rational design and …
Branched Antisense and siRNA Co‐Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy
J Liu, X Lu, T Wu, X Wu, L Han, B Ding - Angewandte Chemie, 2021 - Wiley Online Library
Chemically modified DNA has been widely developed to fabricate various nucleic acid
nanostructures for biomedical applications. Herein, we report a facile strategy for …
nanostructures for biomedical applications. Herein, we report a facile strategy for …
Programmable Tetrahedral DNA‐RNA Nanocages Woven with Stimuli‐Responsive siRNA for Enhancing Therapeutic Efficacy of Multidrug‐Resistant Tumors
C Chen, M Yu, Q Li, Y Zhou, M Zhang, S Cai… - Advanced …, 2024 - Wiley Online Library
Multidrug resistance (MDR) is a major obstacle limiting the effectiveness of chemotherapy
against cancer. The combination strategy of chemotherapeutic agents and siRNA targeting …
against cancer. The combination strategy of chemotherapeutic agents and siRNA targeting …
A tubular DNA nanodevice as a siRNA/chemo‐drug co‐delivery vehicle for combined cancer therapy
Using the DNA origami technique, we constructed a DNA nanodevice functionalized with
small interfering RNA (siRNA) within its inner cavity and the chemotherapeutic drug …
small interfering RNA (siRNA) within its inner cavity and the chemotherapeutic drug …
Multivalent aptamer-modified tetrahedral DNA nanocage demonstrates high selectivity and safety for anti-tumor therapy
X Han, Y Jiang, S Li, Y Zhang, X Ma, Z Wu, Z Wu, X Qi - Nanoscale, 2019 - pubs.rsc.org
The fabrication of aptamers on DNA nanostructures through the DNA origami method has
shown great potential for in vitro and in vivo tumor targeting delivery. Herein, tetrahedral …
shown great potential for in vitro and in vivo tumor targeting delivery. Herein, tetrahedral …
DNA nanoclew templated spherical nucleic acids for siRNA delivery
A superior biocompatible spherical nucleic acid (SNA) conjugate was fabricated by grafting
siRNA onto the surface of a core composed of a spherical DNA nanostructure that we have …
siRNA onto the surface of a core composed of a spherical DNA nanostructure that we have …
A self-assembled DNA tetrahedron as a carrier for in vivo liver-specific delivery of siRNA
While siRNA is a potent therapeutic tool that can silence disease-causing mRNA, its in vivo
potency can be compromised due to the lack of target tissue specificity. Here, we report a …
potency can be compromised due to the lack of target tissue specificity. Here, we report a …